Universe pharmaceuticals inc receives staff determination notice from nasdaq related to delayed annual report

Ji'an, jiangxi, china, feb. 25, 2025 (globe newswire) -- universe pharmaceuticals inc (the “company”) (nasdaq: upc), a pharmaceutical producer and distributor in china, today announced that on february 19, 2025, the company received a staff determination notice from the listing qualifications department of the nasdaq stock market llc (“nasdaq”), notifying the company that it is delinquent in filing its annual report on form 20-f for the fiscal year ended september 30, 2024 (the “form 20-f”) and that this matter serves as an additional basis for delisting the company's securities from nasdaq. the failure to timely file the form 20-f is a violation of nasdaq listing rule 5250(c)(1).
NDAQ Ratings Summary
NDAQ Quant Ranking